Emami Crecimiento futuro

Future controles de criterios 2/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Emami de 11% y 8.2% por año respectivamente. Se prevé que el BPA crezca en un 11.5% al año. Se espera que la rentabilidad financiera sea de 28.9% en 3 años.

Información clave

11.0%

Tasa de crecimiento de los beneficios

11.5%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Personal Products	11.6%
Tasa de crecimiento de los ingresos	8.2%
Rentabilidad financiera futura	28.9%
Cobertura de analistas	Good
Última actualización	22 Apr 2024

Actualizaciones recientes sobre el crecimiento futuro

Emami Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Jan 29

Recent updates

These 4 Measures Indicate That Emami (NSE:EMAMILTD) Is Using Debt Reasonably Well

Feb 27

Emami (NSE:EMAMILTD) Is Due To Pay A Dividend Of ₹4.00

Feb 09

Here's Why We Think Emami (NSE:EMAMILTD) Might Deserve Your Attention Today

Feb 04

Emami's (NSE:EMAMILTD) Dividend Will Be ₹4.00

Nov 18

Emami (NSE:EMAMILTD) Seems To Use Debt Quite Sensibly

Nov 13

With EPS Growth And More, Emami (NSE:EMAMILTD) Makes An Interesting Case

Oct 24

Is Now An Opportune Moment To Examine Emami Limited (NSE:EMAMILTD)?

Sep 27

We Ran A Stock Scan For Earnings Growth And Emami (NSE:EMAMILTD) Passed With Ease

Jul 26

Emami (NSE:EMAMILTD) Could Easily Take On More Debt

Jul 08

Is Now The Time To Put Emami (NSE:EMAMILTD) On Your Watchlist?

Apr 14

Is Emami (NSE:EMAMILTD) Using Too Much Debt?

Mar 24

Emami (NSE:EMAMILTD) Has Affirmed Its Dividend Of ₹4.00

Feb 06

Should You Investigate Emami Limited (NSE:EMAMILTD) At ₹486?

Jan 19

Is Emami (NSE:EMAMILTD) A Risky Investment?

Dec 13

If You Like EPS Growth Then Check Out Emami (NSE:EMAMILTD) Before It's Too Late

Nov 25

Is There Now An Opportunity In Emami Limited (NSE:EMAMILTD)?

Oct 21

Is Emami (NSE:EMAMILTD) Using Too Much Debt?

Sep 08

Here's Why I Think Emami (NSE:EMAMILTD) Is An Interesting Stock

Aug 20

Why Emami Limited (NSE:EMAMILTD) Could Be Worth Watching

Jul 16

Is Emami (NSE:EMAMILTD) A Risky Investment?

Jun 09

Here's Why I Think Emami (NSE:EMAMILTD) Might Deserve Your Attention Today

May 21

Is It Time To Consider Buying Emami Limited (NSE:EMAMILTD)?

Apr 04

Is Emami Limited's (NSE:EMAMILTD) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Mar 17

Tread With Caution Around Emami Limited's (NSE:EMAMILTD) 1.8% Dividend Yield

Feb 27

Here's Why We Think Emami (NSE:EMAMILTD) Is Well Worth Watching

Feb 12

Don't Race Out To Buy Emami Limited (NSE:EMAMILTD) Just Because It's Going Ex-Dividend

Jan 30

Emami Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Jan 29

What Is The Ownership Structure Like For Emami Limited (NSE:EMAMILTD)?

Jan 22

Investors Who Bought Emami (NSE:EMAMILTD) Shares A Year Ago Are Now Up 51%

Jan 09

What Does Emami's (NSE:EMAMILTD) CEO Pay Reveal?

Dec 25

Here's Why We Think Emami's (NSE:EMAMILTD) Statutory Earnings Might Be Conservative

Dec 10

At ₹416, Is Emami Limited (NSE:EMAMILTD) Worth Looking At Closely?

Nov 25

It Might Not Be A Great Idea To Buy Emami Limited (NSE:EMAMILTD) For Its Next Dividend

Nov 07

Previsiones de crecimiento de beneficios e ingresos

NSEI:EMAMILTD - Estimaciones futuras de los analistas y datos financieros pasados (INR Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
3/31/2027	45,860	10,755	10,116	N/A	2
3/31/2026	42,421	9,243	9,253	N/A	23
3/31/2025	38,807	8,157	8,278	N/A	23
3/31/2024	35,735	7,396	7,816	N/A	24
12/31/2023	35,228	7,191	N/A	N/A	N/A
9/30/2023	35,092	6,978	8,133	8,461	N/A
6/30/2023	34,581	7,035	N/A	N/A	N/A
3/31/2023	34,057	6,396	7,084	7,489	N/A
12/31/2022	33,428	8,511	N/A	N/A	N/A
9/30/2022	33,311	8,339	1,423	6,281	N/A
6/30/2022	33,094	8,350	N/A	N/A	N/A
3/31/2022	31,872	8,390	1,603	6,439	N/A
12/31/2021	31,524	5,707	N/A	N/A	N/A
9/30/2021	31,142	5,597	7,300	7,710	N/A
6/30/2021	30,601	4,929	N/A	N/A	N/A
3/31/2021	28,805	4,547	8,878	9,215	N/A
12/31/2020	26,825	3,903	N/A	N/A	N/A
9/30/2020	25,615	3,257	6,250	6,740	N/A
6/30/2020	24,876	3,033	N/A	N/A	N/A
3/31/2020	26,549	3,029	3,717	5,307	N/A
12/31/2019	27,609	3,357	N/A	N/A	N/A
9/30/2019	27,593	3,292	4,484	6,411	N/A
6/30/2019	27,272	3,158	N/A	N/A	N/A
3/31/2019	26,946	3,032	4,145	5,537	N/A
12/31/2018	26,703	3,073	N/A	N/A	N/A
9/30/2018	26,162	3,168	N/A	N/A	N/A
6/30/2018	26,161	3,328	N/A	N/A	N/A
3/31/2018	25,305	3,071	4,641	5,878	N/A
12/31/2017	24,875	3,302	N/A	N/A	N/A
9/30/2017	24,446	3,174	N/A	N/A	N/A
6/30/2017	23,887	2,848	N/A	N/A	N/A
3/31/2017	24,882	3,404	N/A	7,296	N/A
12/31/2016	27,855	3,347	N/A	N/A	N/A
9/30/2016	27,849	3,347	N/A	N/A	N/A
6/30/2016	27,310	3,291	N/A	N/A	N/A
3/31/2016	23,583	3,635	N/A	5,616	N/A
12/31/2015	25,067	4,215	N/A	N/A	N/A
9/30/2015	24,104	4,711	N/A	N/A	N/A
6/30/2015	23,254	5,025	N/A	N/A	N/A
3/31/2015	22,172	4,856	N/A	5,340	N/A
12/31/2014	21,093	4,584	N/A	N/A	N/A
9/30/2014	20,017	4,254	N/A	N/A	N/A
6/30/2014	19,189	4,126	N/A	N/A	N/A
3/31/2014	18,208	4,025	N/A	4,282	N/A
12/31/2013	18,316	3,853	N/A	N/A	N/A
9/30/2013	17,954	3,496	N/A	N/A	N/A
6/30/2013	17,493	3,288	N/A	N/A	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (11% al año) de EMAMILTD es superior a la tasa de ahorro (6.7%).

Beneficios vs. Mercado: Se prevé que los beneficios (11% al año) de EMAMILTD crezcan menos que el mercado Indian (18% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de EMAMILTD crezcan, pero no significativamente.

Ingresos vs. Mercado: Se prevé que los ingresos (8.2% al año) de EMAMILTD crezcan más despacio que el mercado de Indian (10.3% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 8.2% al año) de EMAMILTD crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de EMAMILTD sea alta dentro de 3 años (28.9%)

Emami Crecimiento futuro

Future controles de criterios 2/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Price target increased by 7.6% to ₹517

Price target decreased by 7.3% to ₹510

Price target increased to ₹619

Emami Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Price target raised to ₹510

Price target raised to ₹382

Recent updates

Emami Limited (BSE:531162) signed a share purchase agreement to acquire 4.64% stake in Brillare Science Pvt. Ltd. from founder and other shareholders of Brillare Science Pvt. Ltd.

Is There Now An Opportunity In Emami Limited (NSE:EMAMILTD)?

Dividend of ₹4.00 announced

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Emami Limited Approves Second Interim Dividend for the Financial Year 2023-24

Investor sentiment improves as stock rises 16%

Emami (NSE:EMAMILTD) Seems To Use Debt Rather Sparingly

Emami (NSE:EMAMILTD) Has Affirmed Its Dividend Of ₹4.00

Emami Limited Declares Interim Dividend for the Financial Year 2023-24

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Emami Limited (BSE:531162) completed the acquisition of 26% stake in Axiom Ayurveda Private Limited

Emami Limited (BSE:531162) entered into definitive agreement to acquire 26% stake in Axiom Ayurveda Private Limited.

Emami Limited Announces Change in Management

Manipal Health Enterprises Pvt Ltd acquired 84% stake in AMRI Hospitals Ltd. from Emami Limited (BSE:531162).

Manipal Health Enterprises Pvt Ltd acquired 84% stake in AMRI Hospitals Ltd. from Emami Limited (BSE:531162).

Emami Limited Announces Changes to the Senior Management Personnel

Insider recently bought ₹1.0m worth of stock

Emami May Seal AMRI Sale to Manipal Group This Month

Price target increased by 7.6% to ₹517

Emami Limited Announces Cessation of Mr. Vinod Rao, President-CCD, Personnel of Senior Management Effective from the Closing Hours of July 31, 2023

Is Now The Time To Look At Buying Emami Limited (NSE:EMAMILTD)?

Full year 2023 earnings: EPS misses analyst expectations

Emami Limited to Report Q4, 2024 Results on May 30, 2024

Emami Limited Proposes Two Interim Dividends for the Financial Year 2022-23

Emami Limited, Annual General Meeting, Aug 23, 2023

Does Emami (NSE:EMAMILTD) Have A Healthy Balance Sheet?

Emami Limited to Report Q1, 2024 Results on Aug 07, 2023

Emami Limited Approves Executive Changes

Full year 2023 earnings: EPS misses analyst expectations

What Is Emami Limited's (NSE:EMAMILTD) Share Price Doing?

These 4 Measures Indicate That Emami (NSE:EMAMILTD) Is Using Debt Reasonably Well

Emami (NSE:EMAMILTD) Is Due To Pay A Dividend Of ₹4.00

Price target decreased by 7.3% to ₹510

Third quarter 2023 earnings: EPS exceeds analyst expectations

Emami Limited Declares Second Interim Dividend for the Financial Year 2022-23

Here's Why We Think Emami (NSE:EMAMILTD) Might Deserve Your Attention Today

Emami Limited to Report Q3, 2023 Results on Feb 03, 2023

Max Healthcare Reportedly Eyeing AMRI Hospitals

Emami's (NSE:EMAMILTD) Dividend Will Be ₹4.00

Second quarter 2023 earnings: EPS exceeds analyst expectations

Emami (NSE:EMAMILTD) Seems To Use Debt Quite Sensibly

Second quarter 2023 earnings: EPS exceeds analyst expectations

Emami Limited Declares Interim Dividend for the Financial Year 2022-23

With EPS Growth And More, Emami (NSE:EMAMILTD) Makes An Interesting Case

Emami Limited to Report Q2, 2023 Results on Nov 11, 2022

Is Now An Opportune Moment To Examine Emami Limited (NSE:EMAMILTD)?

Emami Limited, Annual General Meeting, Sep 09, 2022

First quarter 2023 earnings released: EPS: ₹1.67 (vs ₹1.75 in 1Q 2022)

We Ran A Stock Scan For Earnings Growth And Emami (NSE:EMAMILTD) Passed With Ease

Emami Limited (BSE:531162) acquired 30% stake in Cannis Lupus Services India Private Limited.

Emami Limited to Report Q1, 2023 Results on Jul 29, 2022

Emami (NSE:EMAMILTD) Could Easily Take On More Debt

Full year 2022 earnings: EPS exceeds analyst expectations

Is Now The Time To Put Emami (NSE:EMAMILTD) On Your Watchlist?

Emami Limited Announces Executive Changes

Is Emami (NSE:EMAMILTD) Using Too Much Debt?

Emami Limited (BSE:531162) acquired 19% equity stake in Tru Native F&B Private Limited.

Emami (NSE:EMAMILTD) Has Affirmed Its Dividend Of ₹4.00

Emami Limited (BSE:531162) announces an Equity Buyback for INR 1,620 million worth of its shares.

Emami Ltd Restructures Its Board, Effective April 1, 2022

Third quarter 2022 earnings: EPS exceeds analyst expectations

Emami Limited Announces Declaration of Second Interim Dividend

Should You Investigate Emami Limited (NSE:EMAMILTD) At ₹486?

Is Emami (NSE:EMAMILTD) A Risky Investment?

If You Like EPS Growth Then Check Out Emami (NSE:EMAMILTD) Before It's Too Late

Second quarter 2022 earnings released: EPS ₹4.17 (vs ₹2.66 in 2Q 2021)

Upcoming dividend of ₹4.00 per share

Is There Now An Opportunity In Emami Limited (NSE:EMAMILTD)?

Is Emami (NSE:EMAMILTD) Using Too Much Debt?

Emami Limited to Hit the Indian Market with Its Newest Offering Emasol-A Complete Range for Home Hygiene Products